Zobrazeno 1 - 10
of 22
pro vyhledávání: '"He, Weiwu"'
Autor:
Chen, Danqing, Tan, Shuguang, Zhang, Hao, Wang, Haiyuan, He, Weiwu, Shi, Rui, Tong, Zhou, Zhu, Jianhua, Cheng, Hao, Gao, Shan, Chai, Yan, Qi, Jianxun, Xiao, Minghui, Yan, Jinghua, Gao, George F.
Publikováno v:
In iScience 26 April 2019 14:113-124
Autor:
Li, Ying, Chen, Rui, Zhou, Qian, Xu, Zhisheng, Li, Chao, Wang, Shuai, Mao, Aiping, Zhang, Xiaodong, He, Weiwu, Shu, Hong-Bing
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2012 Jul . 109(29), 11770-11775.
Externí odkaz:
https://www.jstor.org/stable/41685152
Autor:
Shuguang Tan, Jianhua Zhu, Yan Chai, Rui Shi, Zhou Tong, He Weiwu, George F. Gao, Jianxun Qi, Shan Gao, Chen Danqing, Jinghua Yan, Minghui Xiao, Hao Zhang, Hao Cheng, Haiyuan Wang
Publikováno v:
iScience
iScience, Vol 14, Iss, Pp 113-124 (2019)
iScience, Vol 14, Iss, Pp 113-124 (2019)
Summary Programmed cell death 1 (PD-1)/PD-1 ligand-1 (PD-L1)-blocking monoclonal antibodies (mAbs) have taken center stage for tumor immune checkpoint therapy. Identification of the “hotspots” on PD-1 for mAbs will help to develop next-generation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb198d96143899573ad8c90bc82da75
https://doi.org/10.1016/j.isci.2019.03.017
https://doi.org/10.1016/j.isci.2019.03.017
Autor:
Guangli Wang, Zhongwu Li, Lixin Zhou, Ma Donghui, Min Zhao, Shu Youmin, Kehu Yuan, Wei Fu, Jian Chen, Qi Lili, Boyang Chu, Huibo Liu, Guiyin Wu, He Weiwu, Xiaozheng Huang, Yi Shen
Publikováno v:
The FASEB Journal. 29
Human epidermal growth factor receptor 2 (HER2) is an orphan receptor tyrosine kinase member of the EGFR families and is found to be a key tumor driver gene. In breast cancer and gastric cancer, HER2 amplification can be effectively treated by its ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76ae735c710fe4d3c05af0dff826d951
https://doi.org/10.1096/fasebj.29.1_supplement.417.8
https://doi.org/10.1096/fasebj.29.1_supplement.417.8
Autor:
He Weiwu, Shu Youmin, Wei Fu, Hsiangmin Emily Lu, Kehu Yuan, Ma Donghui, Boyang Chu, Guangli Wang
Publikováno v:
The FASEB Journal. 29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a702ae43ab9f2753d453b64b1120d59a
https://doi.org/10.1096/fasebj.29.1_supplement.417.10
https://doi.org/10.1096/fasebj.29.1_supplement.417.10
Publikováno v:
The FASEB Journal. 29
Approximately 5%-22% of non-small cell lung cancer (NSCLC) patients with secondary resistance to EGFR TKIs had evidence of amplification of the Met oncogene. This dysregulation of Met signaling was implicated in the proliferation and eventual metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b10c7c0e13de5a30c769eae45355529e
https://doi.org/10.1096/fasebj.29.1_supplement.lb118
https://doi.org/10.1096/fasebj.29.1_supplement.lb118
Autor:
Huibo Liu, Kehu Yuan, Chen Caiwei, He Weiwu, Ma Donghui, Wu Yipan, Guangli Wang, Boyang Chu, Mu-lan Jin, Wei Haitao, Yi Shen, Chen Jian, Julie McDowell, Shu Youmin, Qi Lili, Yungang Zhang, Chenlin Wang
Publikováno v:
The FASEB Journal. 29
The anaplastic lymphoma kinase (ALK) rearrangements, mostly EML4-ALK fusion, occur in 3-7% of lung cancer patients and define a patient population that could respond to receptor tyrosine kinase inh...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e889552f14c9cc26c426c1bcdf462d6
https://doi.org/10.1096/fasebj.29.1_supplement.417.11
https://doi.org/10.1096/fasebj.29.1_supplement.417.11
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gu, Zhenyu, Reynolds, Ellen M., Song, Jihwan, Lei, Hong, Feijen, Alie, Yu, Lian, He, Weiwu, MacLaughlin, David T., Raaij, Janny van den Eijnden-van, Donahoe, Patricia K., Li, En
Publikováno v:
Development; June 1999, Vol. 126 Issue: 11 p2551-2561, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.